X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84) 84
female (61) 61
male (59) 59
middle aged (56) 56
index medicus (54) 54
aged (46) 46
hematology (45) 45
adult (39) 39
oncology (39) 39
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
treatment outcome (30) 30
aged, 80 and over (25) 25
history (20) 20
disease-free survival (19) 19
multiple myeloma - drug therapy (19) 19
bortezomib (18) 18
antineoplastic combined chemotherapy protocols - adverse effects (17) 17
multiple myeloma (17) 17
chemotherapy (15) 15
thalidomide - administration & dosage (15) 15
cancer (14) 14
care and treatment (14) 14
therapy (14) 14
adolescent (13) 13
dexamethasone (13) 13
prednisone - administration & dosage (13) 13
hematology, oncology and palliative medicine (12) 12
italy (12) 12
prognosis (12) 12
rituximab (12) 12
survival (12) 12
time factors (12) 12
follow-up studies (11) 11
kaplan-meier estimate (11) 11
thalidomide - analogs & derivatives (11) 11
elderly-patients (10) 10
history and criticism (10) 10
melphalan - administration & dosage (10) 10
recurrence (10) 10
stem-cell transplantation (10) 10
transplantation (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
prednisone - adverse effects (9) 9
transplantation, autologous (9) 9
young adult (9) 9
abridged index medicus (8) 8
analysis (8) 8
antineoplastic agents - therapeutic use (8) 8
doxorubicin - administration & dosage (8) 8
drug therapy (8) 8
multiple myeloma - mortality (8) 8
multiple myeloma - pathology (8) 8
neoplasm staging (8) 8
child (7) 7
disease (7) 7
hodgkin disease - drug therapy (7) 7
induction (7) 7
italian literature (7) 7
medicine & public health (7) 7
non-hodgkins-lymphoma (7) 7
patients (7) 7
prednisone (7) 7
proportional hazards models (7) 7
salvage therapy (7) 7
thalidomide - adverse effects (7) 7
vincristine - administration & dosage (7) 7
autologous transplantation (6) 6
boronic acids - administration & dosage (6) 6
cell biology (6) 6
combination (6) 6
combined modality therapy (6) 6
criticism and interpretation (6) 6
cyclophosphamide - administration & dosage (6) 6
dexamethasone - administration & dosage (6) 6
diagnosis (6) 6
disease progression (6) 6
dosage and administration (6) 6
dose-response relationship, drug (6) 6
drug administration schedule (6) 6
efficacy (6) 6
hemic and lymphatic diseases (6) 6
lenalidomide (6) 6
lymphomas (6) 6
multiple myeloma - therapy (6) 6
multiple-myeloma (6) 6
phase-ii (6) 6
prednisone plus thalidomide (6) 6
prospective studies (6) 6
pyrazines - administration & dosage (6) 6
quality of life (6) 6
randomized controlled-trial (6) 6
remission induction (6) 6
research (6) 6
retrospective studies (6) 6
risk factors (6) 6
safety (6) 6
stem cell transplantation (6) 6
survival rate (6) 6
thalidomide (6) 6
bone marrow (5) 5
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (30) 30
UTL at Downsview - May be requested (26) 26
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Robarts - Storage (7) 7
Pontifical Inst. Mediaeval Studies - Library use only (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (267) 267
Italian (69) 69
Spanish (5) 5
French (4) 4
German (3) 3
Latin (3) 3
Ancient Greek (1) 1
Czech (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1617 - 1629
Summary Background High-dose melphalan plus autologous stem-cell transplantation (ASCT) is the standard approach in transplant-eligible patients with newly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | ONCOLOGY | CONSOLIDATION THERAPY | INITIAL TREATMENT | THALIDOMIDE | BORTEZOMIB | INDUCTION | STEM-CELL TRANSPLANTATION | DEXAMETHASONE COMBINATION | ELDERLY-PATIENTS | MELPHALAN | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Melphalan - therapeutic use | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - therapeutic use | Thalidomide - analogs & derivatives | Multiple Myeloma - therapy | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Maintenance Chemotherapy | Chemotherapy, Adjuvant | Thalidomide - adverse effects | Prednisone - adverse effects | Multiple Myeloma - diagnosis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Disease Progression | Disease-Free Survival | Czech Republic | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Thalidomide - therapeutic use | Australia | Prednisone - therapeutic use | Medical colleges | Cyclophosphamide | Care and treatment | Chemotherapy | Dexamethasone | Multiple myeloma | Stem cells | Product development | Prednisone | Transplantation | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 12, pp. 2077 - 2084
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 800 - 807
Journal Article
Advances in Hematology, ISSN 1687-9104, 2013, Volume 2013, pp. 812605 - 2
Journal Article
Haematologica, ISSN 0390-6078, 11/2013, Volume 98, Issue 11, pp. 1732 - 1738
Journal Article
Journal Article
by Dimopoulos, Meletios A and Dimopoulos, Athanasios and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Weisel, Katja and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Andrzej and Pluta, Agnieszka and Chng, Wee Joo and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Mateos, Maria Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Lee, Jae Hoon and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and ... and TOURMALINE-MM3 Study Grp and TOURMALINE-MM3 study group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 09/2012, Volume 53, Issue 9, pp. 1722 - 1727
Journal Article
Toxins, ISSN 2072-6651, 08/2019, Volume 11, Issue 9, p. 503
species are endophytic fungi that grow on organic matter and are considered food contaminants. The anti-microbial and anti-tumor naphthoquinones fusarubin... 
anhydrofusarubin | caspase-8 | Rauwolfia serpentina | Cladosporium | endophytic fungi | fusarubin | human cancer cell lines | p21
Journal Article